Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) EBT Margin (2016 - 2025)

Sanara MedTech's EBT Margin history spans 15 years, with the latest figure at 2.84% for Q4 2025.

  • For Q4 2025, EBT Margin fell 653.0% year-over-year to 2.84%; the TTM value through Dec 2025 reached 4.73%, up 47.0%, while the annual FY2025 figure was 0.38%, 180.0% up from the prior year.
  • EBT Margin reached 2.84% in Q4 2025 per SMTI's latest filing, down from 4.26% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 4.26% in Q3 2025 to a low of 50.57% in Q4 2021.
  • Average EBT Margin over 5 years is 15.93%, with a median of 13.16% recorded in 2023.
  • Peak YoY movement for EBT Margin: crashed -3276bps in 2021, then skyrocketed 2771bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 50.57% in 2021, then skyrocketed by 46bps to 27.18% in 2022, then surged by 95bps to 1.48% in 2023, then soared by 349bps to 3.69% in 2024, then crashed by -177bps to 2.84% in 2025.
  • Per Business Quant, the three most recent readings for SMTI's EBT Margin are 2.84% (Q4 2025), 4.26% (Q3 2025), and 7.06% (Q2 2025).